Results 211 to 220 of about 433,923 (290)

Corrigendum to Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. [PDF]

open access: yesJ Clin Invest
Sun K   +31 more
europepmc   +1 more source

Perioperative Outcomes of Patients With Pancreatic Neuroendocrine Neoplasms in the Context of Different Body Composition Phenotypes

open access: yesWorld Journal of Surgery, EarlyView.
Pancreatic neuroendocrine neoplasms (pNEN) are rare and heterogeneous tumors with increasing incidence. While surgical resection remains the only curative treatment, perioperative outcomes are influenced by patient‐related risk factors. Recent research highlights body composition (BC) as a prognostic marker in oncological and transplantation surgery ...
Fabiola A. Bechtiger   +12 more
wiley   +1 more source

Understanding the Type 2 Immunity: An Evolving View Beyond Allergic Diseases

open access: yesAllergy, EarlyView.
ABSTRACT Type 2 (T2) immunity is classically associated with defense against helminths and environmental threats, from a physiological perspective, and with allergies and eosinophilic inflammatory diseases, in a pathological sense. However, growing evidence reveals that T2 pathways also support other essential homeostatic functions, including tissue ...
Rodrigo Jiménez‐Saiz   +22 more
wiley   +1 more source

Severe Abdominal Aortic Calcification in Pancreaticoduodenectomy: A Vascular Frailty Marker for Selecting Total Pancreatectomy?

open access: yesANZ Journal of Surgery, EarlyView.
Severe abdominal aortic calcification on preoperative CT may identify vascular frailty in patients undergoing pancreaticoduodenectomy. Integrated with fistula‐risk scores and frailty assessment, it may inform discussion of standard PD versus planned total pancreatectomy in selected high‐risk patients, while AAC alone is not an indication for TP ...
Mohamed Hajri   +3 more
wiley   +1 more source

Intratumoral Microbiome of Metastatic Pancreatic Ductal Adenocarcinoma. [PDF]

open access: yesInt J Mol Sci
Pavlov V   +8 more
europepmc   +1 more source

Cancer pain: current practice and emerging targets

open access: yesBritish Journal of Pharmacology, EarlyView.
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy